Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · 8-K

Alterola Biotech, Inc.

ABTIOTCEQUITYCurrent

Current Report

Filed Sep 30, 2024Accepted Sep 27, 2024, 3:50 PM EDTCIK 1442999Accession 0001663577-24-000255
Share

Company context

Current securities

Recent company filings

  1. 15-15D filingJun 30, 2025
  2. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureJun 30, 2025
  3. NT 10-Q filingFeb 14, 2025
  4. 10-Q filingNov 29, 2024
  5. 10-Q/A filingNov 25, 2024